Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 4, 2010, Pages 792-796

  Ak, Ilknur ^a   Sivrikoz, Muammer Cumhur ^a   Entok, Emre ^a   Vardareli, Erkan ^b  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^b ACIBADEM UNIVERSITY   (Turkey)

Author keywords

F 18 FDG PET CT; Non small cell lung cancer; Tc 99m MDP bone scans

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; MEDRONATE TECHNETIUM TC 99M;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BONE MARROW; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; GLUCOSE METABOLISM; HUMAN; LARGE CELL CARCINOMA; LONG BONE; LUMBAR SPINE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; OSTEOLYSIS; PELVIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; THORACIC SPINAL CORD; THORAX;

AGED; BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M MEDRONATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77949491459     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.11.011     Document Type: Article

References (24)

1. Deslauriers J., and Gregoire J. Clinical and surgical staging of non-small cell lung cancer. Chest 117 (2000) 96-103
2. Marom E.M., McAdams H.P., Erasmus J.J., Goodman P.C., Culhane D.K., Coleman R.E., Herndon J.E., and Patz Jr. E.F. Staging non-small cell lung cancer with whole-body PET. Radiology 212 (1999) 803-809
3. Pieterman R.M., van Putten J.W., Meuzelaar J.J., Mooyaart E.L., Vaalburg W., Koëter G.H., Fidler V., Pruim J., and Groen H.J. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343 (2000) 254-261
4. Bruzzi J.F., and Munden R.F. PET/CT imaging of lung cancer. J Thorac Imaging 21 (2006) 123-136
5. Yang P., Allen M.S., Aubry M.C., Wampfler J.A., Marks R.S., Edell E.S., Thibodeau S., Adjei A.A., Jett J., and Deschamps C. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 128 (2005) 452-462
6. Salvatierra A., Baamonde C., Llamas J.M., Cruz F., and Lopez-Pujol J. Extrathoracic staging of bronchogenic carcinoma. Chest 97 (1990) 1052-1058
7. Napoli L.D., Hansen H.H., Muggia F.M., and Twigg H.L. The incidence of osseous involvement in lung cancer, with special reference to the development of osteoblastic changes. Radiology 108 (1973) 17-21
8. Jacobson A. Bone scanning in metastatic disease. In: Collier B.J., Fogelman I., and Rosenthall L. (Eds). Skeletal nuclear medicine (1996), Mosby, St. Louis 87-123
9. An Y.S., Sun J.S., Park K.J., Hwang S.C., Park K.J., Sheen S.S., Lee S., Lee K.B., and Yoon J.K. Diagnostic performance of (18) F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease. Lung 186 5 (2008) 327-336
10. Chen Y.W., Huang M.Y., Hsieh J.S., Hou M.F., Chou S.H., and Lin C.L. Discordant findings of skeletal metastasis between Tc 99m MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers-two case reports and literature review. Kaohsiung J Med Sci 23 12 (2007) 639-646
11. Fukuchi K., Yamaguchi M., Hayashida K., and Ishida Y. Discrepancy between Tc-99m HMDP bone scan and F-18 FDG positron emission tomographic images in a patient with small cell lung cancer. Clin Nucl Med 28 March (3) (2003) 232-233
12. Garcia J.R., Simo M., Perez G., Soler M., Lopez S., Setoain X., and Lomeña F. 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases. Eur J Nucl Med Mol Imaging 30 12 (2003) 1714 [Epub 2003 November 19]
13. 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Anticancer Res 20 (2000) 2189-2192
14. Bury T., Barreto A., Daenen F., Barthelemy N., Ghaye B., and Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 25 (1998) 1244-1247
15. 18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol 5 (2003) 26-31
16. Lewis P., Griffin S., Marsden P., Gee T., Nunan T., Malsey M., and Dussek J. Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet 344 (1994) 1265-1266
17. Valk P.E., Pounds T.R., Hopkins D.M., Haseman M.K., Hofer G.A., Greiss H.B., Myers R.W., and Lutrin C.L. Staging of non-small cell lung cancer by whole-body positron emission imaging. Ann Thorac Surg 60 (1995) 1573-1582
18. Bury T., Dowlati A., Paulus P., Corhay J.L., Hustinx R., Ghaye B., Radermecker M., and Rigo P. Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. Eur Respir J 10 (1997) 2529-2534
19. Erasmus J.J., Patz Jr. E.F., McAdams H.P., Murray J.G., Herndon J., Coleman R.E., and Goodman P.C. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 168 (1997) 1357-1360
20. Moon D.H., Maddahi J., Silverman D.H., Glaspy J.A., Phelps M.E., and Hoh C.K. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. J Nucl Med 39 (1998) 431-435
21. Gallowitsch H.J., Kresnik E., Gasser J., Kumnig G., Igerc I., Mikosch P., and Lind P. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol 38 (2003) 250-256
22. Galasko C.S.B. Skeletal metastases (1986), Butterworths, London
23. Shreve P.D., Grossman H.B., Gross M.D., and Wahl R.L. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18] fluoro-d-glucose. Radiology 199 (1996) 751-756
24. Yamamoto T., Seino Y., Fukumoto H., Koh G., Yano H., Inagaki N., Yamada Y., Inoue K., Manabe T., and Imura H. Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun 170 (1990) 223-230